Mr. Glenn is the founder and Managing Parter of Windamere Venture Partners. Over the past fifteen years, he has raised or invested over $500 million in emerging medical and technology businesses.

As Managing Director of Windamere he currently serves as director and founder of Kanisa Pharmaceuticals, Inc., Evoke Pharmaceuticals and Planet Technologies. Mr. Glenn is also the past Chairman or founder of Prometheus Laboratories, Inc., Santarus, DexCom, Cadence Pharmaceuticals, NovaCardia, Somaxon, Zogenix, SpineWave, Verus and Conception Technologies.

Prior to his involvement in venture capital, he was the President and CEO of Quidel Corporation (Nasdaq: QDEL) and simultaneously was a founder of La Jolla Pharmaceuticals (Nasdaq: LJPC). Prior to Quidel, Mr. Glenn held various management positions including Division General manager with Allergan (NYSE: AGN).

Mr. Glenn holds a Bachelor of Science degree in Finance and Accounting from California State University at Fullerton.